secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0000950170-25-093832
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics receives Nasdaq bid price deficiency notice; 180 days to cure
----------------------------------------------------------------------------

- Nasdaq notified FibroBiologics on July 1, 2025 that common stock closing bid price was below $1.00 for 30 consecutive trading days.
- Company has until December 29, 2025 to regain compliance by maintaining $1.00+ closing bid for 10 consecutive business days.
- If not cured by deadline, FibroBiologics may qualify for a second 180-day period subject to meeting other listing standards.
- Failure to cure could lead to delisting; Company may consider options to regain compliance, no guarantee of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025093832/0000950170-25-093832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000095017025093832/fblg-20250701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-093832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer